Download PDF
Horm Metab Res 2025; 57(05): 338-345
DOI: 10.1055/a-2586-3681
Original Article: Endocrine Care

Clinical Study on the Correlation Between Cortisol Secretion and Type 2 Diabetes and Hypertension in Patients with Adrenal Tumors

Jiao Jiao
1   Department of Urology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China (Ringgold ID: RIN194024)
,
Xianjun Cao
1   Department of Urology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China (Ringgold ID: RIN194024)
,
Xuan Yi
1   Department of Urology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China (Ringgold ID: RIN194024)
,
Guangbin Li
1   Department of Urology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China (Ringgold ID: RIN194024)
,
Feng Han
1   Department of Urology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China (Ringgold ID: RIN194024)
,
Yu Su 
1   Department of Urology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China (Ringgold ID: RIN194024)
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

This study aimed to investigate the correlation between cortisol secretion and the prevalence of type 2 diabetes (T2D) and hypertension in patients with adrenal tumors. A total of 164 patients with benign adrenal tumors were recruited between January 2019 and December 2024. Cortisol levels were assessed using a 1 mg overnight dexamethasone suppression test, classifying patients into three groups: non-functional adrenal tumors (group A, n=73), minimal autonomous cortisol secretion (MACS, group B, n=64), and MACS with confirmed Cushing’s syndrome (group C, n=27). Statistical analyses compared the prevalence of hypertension and T2D across groups. Cortisol concentrations were measured using high-performance liquid chromatography (HPLC) and ELISA. Logistic regression identified factors influencing hypertension and T2D. The prevalence of hypertension and T2D was significantly higher in group C compared to groups A and B (p<0.05). Cortisol concentrations were higher in groups C and B than in group A (p<0.05), with group C showing the highest levels. Elevated cortisol in MACS patients was associated with increased hypertension risk (p<0.05) and higher rates of T2D (p<0.05). Age was a significant predictor, with a 9% increase in risk for each additional year. Cortisol secretion in adrenal tumor patients is linked to T2D and hypertension. As cortisol levels and age increase, so does the risk of these conditions, highlighting cortisol as a potential biomarker for managing these comorbidities.

Keywords

adrenal tumors - cortisol secretion


Publication History

Received: 15 January 2025

Accepted after revision: 31 March 2025

Article published online:
03 June 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Morbach C, Detomas M. Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study. Eur J Endocrinol 2024; 191: 604-613
    PubMedSearch in Google Scholar
  • 2 Chung R, Garratt J. Adrenal neoplasms: lessons from adrenal multidisciplinary tumor boards. Radiographics 2023; 43: e220191
    PubMedSearch in Google Scholar
  • 3 Rahimi L, Kittithaworn A. Kidney function in patients with adrenal adenomas: a single-center retrospective cohort study. J Clin Endocrinol Metab 2024; 109: e1750-e1758
    PubMedSearch in Google Scholar
  • 4 Vassiliadi DA, Delivanis DA, Papalou O. Approach to the patient with bilateral adrenal masses. J Clin Endocrinol Metab 2024; 109: 2136-2148
    PubMedSearch in Google Scholar
  • 5 Czapla-Iskrzycka A, Świątkowska-Stodulska R, Sworczak K. Comorbidities in mild autonomous cortisol secretion – a clinical review of literature. Exp Clin Endocrinol Diabetes 2022; 130: 567-576
    PubMedSearch in Google Scholar
  • 6 Fan L, Qi X, Lin Y. et al. Fibroblastic reticular-cell tumor of the adrenal gland with multiple relapse events: a case report and literature review. Asian J Surg 2024; 47: 1326-1327
    PubMedSearch in Google Scholar
  • 7 Prete A, Subramanian A. Cardiometabolic disease burden and steroid excretion in benign adrenal tumors : a cross-sectional multicenter study. Ann Intern Med 2022; 175: 325-334
    CrossrefPubMedSearch in Google Scholar
  • 8 Yip L, Duh QY, Wachtel H. et al. American association of endocrine surgeons guidelines for adrenalectomy: executive summary. JAMA Surg 2022; 157: 870-877
    PubMedSearch in Google Scholar
  • 9 Whaley RD, Molligan J, Erickson LA. Adrenal gland solitary fibrous tumor. Mayo Clin Proc 2023; 98: 1735-1736
    PubMedSearch in Google Scholar
  • 10 Montalto S, Sertorio F, Podda M. et al. Bilateral adrenal primary tumor in Stage 4S neuroblastoma: the Italian experience and review of the literature. Pediatr Hematol Oncol 2022; 39: 441-452
    PubMedSearch in Google Scholar
  • 11 Ragnarsson O, Juhlin CC, Torpy DJ. et al. A clinical perspective on ectopic Cushing's syndrome. Trends Endocrinol Metab 2024; 35: 347-360
    CrossrefPubMedSearch in Google Scholar
  • 12 Fassnacht M, Tsagarakis S, Terzolo M. European society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 2023; 189: G1-G42
    CrossrefPubMedSearch in Google Scholar
  • 13 McIntosh R, Hidalgo M, Lobo J. et al. Circulating endothelial and angiogenic cells predict hippocampal volume as a function of HIV status. J Neurovirol 2023; 29: 65-77
    PubMedSearch in Google Scholar
  • 14 Hu Y, He X, Zhang Q. et al. Primary adrenal glomus tumor: the first case report. Urol Int 2022; 106: 317-320
    PubMedSearch in Google Scholar
  • 15 Di Dalmazi G, Goi J, Burrello J. et al. Screening of hypercortisolism among patients with hypertension: an Italian nationwide survey. J Endocrinol Invest 2024; 47: 3029-3038
    PubMedSearch in Google Scholar
  • 16 Yoshida T, Ohe C, Sato G. et al. Adrenal tumor with thrombus in the inferior vena cava. Urology 2022; 160: 17-18
    PubMedSearch in Google Scholar
  • 17 Stumpf PK, Yorke ED, El Naqa I. et al. Modeling of tumor control probability in stereotactic body radiation therapy for adrenal tumors. Int J Radiat Oncol Biol Phys 2021; 110: 217-226
    PubMedSearch in Google Scholar
  • 18 Bancos I, Prete A. Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab 2021; 106: 3331-3353
    PubMedSearch in Google Scholar
  • 19 Pelsma ICM, Fassnacht M. Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. Eur J Endocrinol 2023; 189: S8-S101
    PubMedSearch in Google Scholar
  • 20 Morelli V, Elli FM, Frigerio S. et al. Prevalence and clinical features of armadillo repeat-containing 5 mutations carriers in a single center cohort of patients with bilateral adrenal incidentalomas. Eur J Endocrinol 2023; 189: 242-251
    PubMedSearch in Google Scholar
  • 21 Katabami T, Matsuba R. Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk. Eur J Endocrinol 2022; 186: 645-655
    PubMedSearch in Google Scholar
  • 22 Friedman MR, Badri S, Bowleg L. et al. Intersectional stigma and the non-communicable disease syndemic in the context of HIV: protocol for a multisite, observational study in the USA. BMJ Open 2024; 14: e075368
    PubMedSearch in Google Scholar
  • 23 Jing Y, Hu J. Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study. Ann Intern Med 2022; 175: 1383-1391
    CrossrefPubMedSearch in Google Scholar
  • 24 Bertherat J, Bourdeau I. Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia. Endocr Rev 2023; 44: 567-628
    CrossrefPubMedSearch in Google Scholar
  • 25 Morais JBS, Severo JS, Beserra JB. et al. Association between cortisol, insulin resistance and zinc in obesity: a mini-review. Biol Trace Elem Res 2019; 191: 323-330
    PubMedSearch in Google Scholar
  • 26 Deutschbein T, Reimondo G, Di Dalmazi G. et al. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol 2022; 10: 499-508
    CrossrefPubMedSearch in Google Scholar
  • 27 Kox M, van Eijk LT, Zwaag J. et al. Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans. Proc Natl Acad Sci U S A 2014; 111: 7379-7384
    PubMedSearch in Google Scholar
  • 28 Shi H. A case-control study on the association between serum cortisol and hypertension. J Med Forum 2020; 41: 56-60
    PubMedSearch in Google Scholar
  • 29 Zhang W, Wang M, Zhang Y. Prevalence of hyperglycaemia in patients with adrenocorticotropic hormone-stimulating tumours and its postoperative changes. Chin J Diabetes 2022; 30: 443-447
    PubMedSearch in Google Scholar
  • 30 Favero V, Aresta C, Parazzoli C. et al. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors. Cardiovasc Diabetol 2023; 22: 102
    PubMedSearch in Google Scholar
  • 31 Arruda M, Mello Ribeiro Cavalari E, Pessoa de Paula M. et al. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test. J Hum Hypertens 2017; 32: 3-11
    CrossrefPubMedSearch in Google Scholar
  • 32 Chen AX, Radhakutty A, Drake SM. et al. Cardiovascular risk markers in adults with adrenal incidentaloma and mild autonomous cortisol secretion. J Clin Endocrinol Metab 2024; 109: e1020-e1028
    PubMedSearch in Google Scholar